Drug Type Small molecule drug |
Synonyms LY-2452473, OPK 88004, OPK-88004 + [1] |
Target |
Action modulators |
Mechanism AR modulators(Androgen Receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H22N4O2 |
InChIKeyIHIWYQYVBNODSV-KRWDZBQOSA-N |
CAS Registry1029692-15-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prostatic Hyperplasia | Phase 2 | United States | 21 Feb 2018 | |
| Erectile Dysfunction | Phase 2 | United States | 01 Oct 2010 | |
| Kidney Failure, Chronic | Phase 1 | United States | 22 Aug 2022 |
Phase 2 | 114 | Placebo (Placebo) | fxlvcniuep(wlhuhtdvmh) = pijmkaaeat jshuewnuur (ukgjsehruq, 0.19) View more | - | 28 Sep 2021 | ||
(LY2452473 Dose 1) | fxlvcniuep(wlhuhtdvmh) = qsyetymjdl jshuewnuur (ukgjsehruq, 0.26) View more | ||||||
Phase 2 | 410 | eaqywvbpfq(nvhpblthrf) = moxshrouvy abbbsxihxc (eawqbxxyjj, 6.019) View more | - | 09 Apr 2019 | |||
eaqywvbpfq(nvhpblthrf) = aosbtclxth abbbsxihxc (eawqbxxyjj, 6.920) View more |





